You Might Also Like
Explore This IssueSeptember 2014
Also By This Author
Eric L. Matteson, MD
Dr. Matteson selected as vice president of the Rheumatology Research Foundation
The Rheumatology Research Foundation, the charitable foundation of the American College of Rheumatology, is the “largest private funder for rheumatology research and support for new and established investigators,” according to the Foundation’s new vice president, Eric L. Matteson, MD, chair of rheumatology at the Mayo Clinic, Rochester, Minn., who has more than 25 years of experience.
The Foundation’s president, David Karp, MD, PhD, says, “We are fortunate that Dr. Matteson is willing to share his experience in rheumatology and on the Simple Tasks campaign with us. He will be able to steer the Foundation down a continued path of success while helping us raise awareness of our organization and the work it does.”
Dr. Matteson says, “The job of vice president is to assist the president in the overall vision of funding, to help develop strategies for research funding, to meet with donors, to work with the board to identify talent and to administer grants.”
Deciding which investigators to support leads to “very rewarding [results] when we can see the successes of our students and fellows,” says Dr. Matteson.
Pércio S. Gulko, MD
Dr. Gulko named chief of rheumatology for the Mount Sinai Health System
In what he characterizes as “a dream come true,” Pércio S. Gulko, MD, is the new chief of the Division of Rheumatology in the Samuel Bronfman Department of Medicine in the Icahn School of Medicine, Mount Sinai, New York.
Dr. Gulko looks forward to working with a “fantastic team of medical chemists, genomists, system biologists and immunologists. Together, we will build upon the Division’s existing success by combining breakthrough research and extraordinary patient care for those who suffer from rheumatologic diseases.” He plans to expand research and clinical trials, as well as identify new treatments.
His own research in rheumatoid arthritis has focused on identifying and characterizing new genes in regulating the disease severity and joint damage of rheumatoid arthritis. Dr. Gulko has published more than 60 peer-reviewed articles. He was most recently professor and director of the Laboratory of Experimental Rheumatology at the Center for Genomics and Human Genetics at the Feinstein Institute for Medical Research, research division of North Shore-LIJ Health System in New York.
Désirée van der Heijde, MD, PhD
Honored for publications